D-1169-2022 Class II Ongoing

Recalled by Noven Pharmaceuticals Inc — Miami, FL

FDA drug recall D-1169-2022 was initiated by Noven Pharmaceuticals Inc on Jun 24, 2022 and is designated Class II. Reason for recall: Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer. The recall status is ongoing. Affected quantity: 8,559 cartons.

Recall details

Product Type
Drugs
Report Date
Jul 6, 2022
Initiation Date
Jun 24, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,559 cartons

Product description

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186. NDC 68968-5552-3

Reason for recall

Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot: 91272 Exp. 12/22.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1169-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1169-2022. Report a data issue: hello@regdatalab.com.